Smad6 negatively regulates interleukin 1-receptor–Toll-like receptor signaling through direct interaction with the adaptor Pellino-1 (original) (raw)
Roberts, A.B. & Sporn, M.B. Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors8, 1–9 (1993). ArticleCAS Google Scholar
Whitman, M. Smads and early developmental signaling by the TGF-β superfamily. Genes Dev.12, 2445–2462 (1998). ArticleCAS Google Scholar
Blobe, G.C., Schiemann, W.P. & Lodish, H.F. Role of transforming growth factor-β in human disease. N. Engl. J. Med.342, 1350–1358 (2000). ArticleCAS Google Scholar
de Caestecker, M.P., Piek, E. & Roberts, A.B. Role of transforming growth factor-β signaling in cancer. J. Natl. Cancer Inst.92, 1388–1402 (2000). ArticleCAS Google Scholar
Hayashi, H. et al. The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell89, 1165–1173 (1997). ArticleCAS Google Scholar
Imamura, T. et al. Smad6 inhibits signalling by the TGF-β superfamily. Nature389, 622–626 (1997). ArticleCAS Google Scholar
Nakao, A. et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature389, 631–635 (1997). ArticleCAS Google Scholar
Monteleone, G. et al. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest.108, 601–609 (2001). ArticleCAS Google Scholar
Dong, C. et al. Deficient Smad7 expression: a putative molecular defect in scleroderma. Proc. Natl. Acad. Sci. USA99, 3908–3913 (2002). ArticleCAS Google Scholar
Asano, Y., Ihn, H., Yamane, K., Kubo, M. & Tamaki, K. Impaired Smad7-Smurf–mediated negative regulation of TGF-β signaling in scleroderma fibroblasts. J. Clin. Invest.113, 253–264 (2004). ArticleCAS Google Scholar
Kavsak, P. et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol. Cell6, 1365–1375 (2000). ArticleCAS Google Scholar
Ebisawa, T. et al. Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem.276, 12477–12480 (2001). ArticleCAS Google Scholar
Murakami, G., Watabe, T., Takaoka, K., Miyazono, K. & Imamura, T. Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. Mol. Biol. Cell14, 2809–2817 (2003). ArticleCAS Google Scholar
Ulloa, L., Doody, J. & Massague, J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature397, 710–713 (1999). ArticleCAS Google Scholar
Bitzer, M. et al. A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/RelA. Genes Dev.14, 187–197 (2000). CASPubMedPubMed Central Google Scholar
Topper, J.N. et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA94, 9314–9319 (1997). ArticleCAS Google Scholar
Bai, S., Shi, X., Yang, X. & Cao, X. Smad6 as a transcriptional corepressor. J. Biol. Chem.275, 8267–8270 (2000). ArticleCAS Google Scholar
Bai, S. & Cao, X. A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-β signaling. J. Biol. Chem.277, 4176–4182 (2002). ArticleCAS Google Scholar
Lin, X. et al. Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol. Cell. Biol.23, 9081–9093 (2003). ArticleCAS Google Scholar
Grosshans, J., Schnorrer, F. & Nusslein-Volhard, C. Oligomerisation of Tube and Pelle leads to nuclear localisation of dorsal. Mech. Dev.81, 127–138 (1999). ArticleCAS Google Scholar
Jiang, Z. et al. Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J. Biol. Chem.278, 10952–10956 (2003). ArticleCAS Google Scholar
Yu, K.Y. et al. Cutting edge: mouse pellino-2 modulates IL-1 and lipopolysaccharide signaling. J. Immunol.169, 4075–4078 (2002). ArticleCAS Google Scholar
Jensen, L.E. & Whitehead, A.S. Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein. J. Immunol.171, 1500–1506 (2003). ArticleCAS Google Scholar
Janeway, C.A., Jr. & Medzhitov, R. Innate immune recognition. Annu. Rev. Immunol.20, 197–216 (2002). ArticleCAS Google Scholar
Akira, S., Takeda, K. & Kaisho, T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol.2, 675–680 (2001). ArticleCAS Google Scholar
Kimbrell, D.A. & Beutler, B. The evolution and genetics of innate immunity. Nat. Rev. Genet.2, 256–267 (2001). ArticleCAS Google Scholar
Dinarello, C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol.16, 457–499 (1998). ArticleCAS Google Scholar
O'Neill, L. The Toll/interleukin-1 receptor domain: a molecular switch for inflammation and host defense. Biochem. Soc. Trans.28, 557–563 (2000). ArticleCAS Google Scholar
Martin, M.U. & Wesche, H. Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family. Biochim. Biophys. Acta1592, 265–280 (2002). ArticleCAS Google Scholar
Afrakhte, M. et al. Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun.249, 505–511 (1998). ArticleCAS Google Scholar
Maric, I. et al. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J. Cell. Physiol.196, 258–264 (2003). ArticleCAS Google Scholar
Jensen, L.E. & Whitehead, A.S. Pellino2 activates the mitogen activated protein kinase pathway. FEBS Lett.545, 199–202 (2003). ArticleCAS Google Scholar
Dinarello, C.A. Biologic basis for interleukin-1 in disease. Blood87, 2095–2147 (1996). CASPubMed Google Scholar
Medzhitov, R. Toll-like receptors and innate immunity. Nat. Rev. Immunol.1, 135–145 (2001). ArticleCAS Google Scholar
Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol.21, 335–376 (2003). ArticleCAS Google Scholar
O'Neill, L.A. & Dinarello, C.A. The IL-1 receptor/Toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol. Today21, 206–209 (2000). ArticleCAS Google Scholar
Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science282, 2085–2088 (1998). ArticleCAS Google Scholar
Lorenz, E., Mira, J.P., Frees, K.L. & Schwartz, D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch. Intern. Med.162, 1028–1032 (2002). ArticleCAS Google Scholar
Aliprantis, A.O. et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science285, 736–739 (1999). ArticleCAS Google Scholar
Hou, L., Sasaki, H. & Stashenko, P. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infect. Immun.68, 4681–4687 (2000). ArticleCAS Google Scholar
Cook, D.N., Pisetsky, D.S. & Schwartz, D.A. Toll-like receptors in the pathogenesis of human disease. Nat. Immunol.5, 975–979 (2004). ArticleCAS Google Scholar
McCartney-Francis, N., Jin, W. & Wahl, S.M. Aberrant Toll receptor expression and endotoxin hypersensitivity in mice lacking a functional TGF-β1 signaling pathway. J. Immunol.172, 3814–3821 (2004). ArticleCAS Google Scholar
Neumann, D., Kollewe, C., Martin, M.U. & Boraschi, D. The membrane form of the type II IL-1 receptor accounts for inhibitory function. J. Immunol.165, 3350–3357 (2000). ArticleCAS Google Scholar
Brint, E.K. et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol.5, 373–379 (2004). ArticleCAS Google Scholar
Wald, D. et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol.4, 920–927 (2003). ArticleCAS Google Scholar
Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell110, 191–202 (2002). ArticleCAS Google Scholar
Burns, K. et al. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med.197, 263–268 (2003). Article Google Scholar
Kinjyo, I. et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity17, 583–591 (2002). ArticleCAS Google Scholar
Naiki, Y. et al. Transforming growth factor-β differentially inhibits MyD88-dependent, but not TRAM- and TRIF-dependent, lipopolysaccharide-induced TLR4 signaling. J. Biol. Chem.280, 5491–5495 (2005). ArticleCAS Google Scholar
Kawai, T. et al. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity11, 115–122 (1999). ArticleCAS Google Scholar
Ju, E.M. et al. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-β1 depends on the enhanced TGF-β signaling and requires the decreased phosphorylation of PKB/Akt. Biochem. Biophys. Res. Commun.328, 1170–1181 (2005). ArticleCAS Google Scholar
Kim, B.C. et al. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor-β signaling by binding to Smad7 and promoting its degradation. Mol. Cell. Biol.24, 2251–2262 (2004). ArticleCAS Google Scholar
Fujii, M. et al. Roles of bone morphogenetic protein type I receptors and Smad proteins in osteoblast and chondroblast differentiation. Mol. Biol. Cell10, 3801–3813 (1999). ArticleCAS Google Scholar
Kim, B.C., Mamura, M., Choi, K.S., Calabretta, B. & Kim, S.J. Transforming growth factor-β1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells. Mol. Cell. Biol.22, 1369–1378 (2002). ArticleCAS Google Scholar
Park, S.H. et al. Mechanism of induction of transforming growth factor-β type II receptor gene expression by v-Src in murine myeloid cells. Cell Growth Differ.12, 9–18 (2001). CASPubMed Google Scholar
Cardosa, M.J., Gordon, S., Hirsch, S., Springer, T.A. & Porterfield, J. Interaction of West Nile Virus with primary murine macrophage: Role of cell activation and receptors for antibody and complement. J. Virol.57, 952–959 (1986). CASPubMedPubMed Central Google Scholar